RA
AMGN icon

Rise Advisors’s Amgen AMGN Stock Holding History

Rise Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
1,169
+44
+4% +$15.1K 0.12% 59
2026
Q1 		$397K Buy
1,125
+15
+1% +$5.35K 0.14% 54
2025
Q4 		$363K Sell
1,110
-16
-1% -$5.08K 0.13% 60
2025
Q3 		$318K Buy
1,126
+91
+9% +$26.4K 0.11% 68
2025
Q2 		$289K Sell
1,035
-54
-5% -$15.3K 0.11% 70
2025
Q1 		$339K Buy
1,089
+578
+113% +$171K 0.15% 62
2024
Q4 		$133K Sell
511
-105
-17% -$31.2K 0.06% 119
2024
Q3 		$198K Sell
616
-11
-2% -$3.6K 0.1% 90
2024
Q2 		$196K Buy
627
+4
+0.6% +$1.18K 0.1% 97
2024
Q1 		$177K Buy
623
+296
+91% +$86.6K 0.09% 99
2023
Q4 		$94.2K Buy
327
+300
+1,111% +$81.7K 0.07% 109
2023
Q3 		$7.24K Hold
27
– – 0.01% 342
2023
Q2 		$5.93K Sell
27
-25
-48% -$5.8K ﹤0.01% 402
2023
Q1 		$12.7K Buy
52
+4
+8% +$982 0.01% 325
2022
Q4 		$12.6K Hold
48
– – 0.01% 319
2022
Q3 		$11K Buy
48
+1
+2% +$242 0.01% 321
2022
Q2 		$11K Hold
47
– – 0.01% 320
2022
Q1 		$11K Buy
47
+1
+2% +$230 0.01% 310
2021
Q4 		$10.5K Buy
+46
New +$9.71K 0.01% 321

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rise Advisors's AMGN Position: Q2 2026 in Review

Rise Advisors increased its Amgen (AMGN) stake by 3.9% in Q2 2026, buying an estimated $15.1K and bringing the position to 1,169 shares worth $423K. The position accounts for 0.12% of the portfolio, ranked #59.

Rise Advisors first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rise Advisors held 1,169 shares of Amgen worth $423K as of Q2 2026.
  • Rise Advisors bought 44 Amgen shares in Q2 2026, an estimated $15.1K.
  • Amgen made up 0.12% of Rise Advisors's portfolio in Q2 2026, its #59 holding.
  • Rise Advisors first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rise Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.